BioCardia BCDA
NASDAQ BCDA
$1.04 +0.02 (+1.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioCardia (BCDA) Sales of Property, Plant and Equipment (2011)

Updated

BioCardia's Sales of Property, Plant and Equipment was $560,000 in Q4 2011.

Analysis

BioCardia (BCDA) Sales of Property, Plant and Equipment (2011) Analysis & Trends

For FY2011, Sales of Property, Plant and Equipment at BioCardia came in at $17.18 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioCardia 12.58 Mn -287,001.74 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 560,000.00
Sep 30, 2011 -411,000.00
API Access

BioCardia Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=BCDA&period=max&api_key=YOUR_API_KEY